$46.1 Million is the total value of PIPER SANDLER & CO.'s 20 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 105.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CMRX | Exit | CHIMERIX INC | $0 | – | -22 | -100.0% | 0.00% | – |
| SGNT | Exit | SAGENT PHARMACEUTICALS INC | $0 | – | -185 | -100.0% | -0.01% | – |
| COLL | Exit | COLLEGIUM PHARMACEUTICAL INC | $0 | – | -599 | -100.0% | -0.04% | – |
| OREX | Exit | OREXIGEN THERAPEUTICS INC | $0 | – | -9,809 | -100.0% | -0.04% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -201 | -100.0% | -0.06% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -700 | -100.0% | -0.06% | – |
| Exit | AIRTRAN HLDGS INCnote 5.250%11/0 | $0 | – | -9,000 | -100.0% | -0.07% | – | |
| RLYP | Exit | RELYPSA INC | $0 | – | -1,702 | -100.0% | -0.12% | – |
| Exit | APOLLO INVT CORPnote 5.750% 1/1 | $0 | – | -125,000 | -100.0% | -0.32% | – | |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -2,256 | -100.0% | -0.37% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -1,385 | -100.0% | -0.37% | – |
| LULU | Exit | LULULEMON ATHLETICA INC | $0 | – | -3,353 | -100.0% | -0.45% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -5,929 | -100.0% | -0.46% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -1,976 | -100.0% | -0.51% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -3,825 | -100.0% | -1.22% | – |
| Exit | ARES CAP CORPnote 5.125% 6/0 | $0 | – | -500,000 | -100.0% | -1.27% | – | |
| Exit | SPECTRANETICS CORPmtnf 2.625% 6/0 | $0 | – | -1,000,000 | -100.0% | -1.91% | – | |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDadr | $0 | – | -11,559 | -100.0% | -1.93% | – |
| Exit | ARES CAP CORPnote 5.750% 2/0 | $0 | – | -1,005,000 | -100.0% | -2.55% | – | |
| Exit | NEWMONT MINING CORPnote 1.625% 7/1 | $0 | – | -1,206,000 | -100.0% | -3.00% | – | |
| Exit | ROYAL GOLD INCnote 2.875% 6/1 | $0 | – | -1,801,000 | -100.0% | -4.15% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SHATTUCK LABS INC | 12 | Q3 2023 | 4.1% |
| U S WELL SVCS INC | 12 | Q4 2021 | 3.7% |
| SPDR S&P 500 ETF TR | 11 | Q2 2016 | 81.8% |
| GENCORP INC | 10 | Q3 2016 | 32.4% |
| WELLPOINT INC | 9 | Q4 2022 | 25.5% |
| INCONTACT INC | 9 | Q1 2016 | 0.6% |
| WESCO INTL INC | 8 | Q3 2015 | 13.1% |
| SOUTH JERSEY INDS INC | 8 | Q4 2021 | 5.1% |
| OPPFI INC | 8 | Q3 2023 | 0.6% |
| OPPFI INC | 8 | Q3 2023 | 0.1% |
View PIPER SANDLER & CO.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-13 |
| MA-I/A | 2024-05-08 |
| MA-I/A | 2024-05-08 |
| MA-I/A | 2024-05-01 |
| FOCUSN | 2024-03-22 |
| MA-A | 2024-03-20 |
| MA-I/A | 2024-03-04 |
| X-17A-5 | 2024-02-27 |
| MA-I | 2024-02-26 |
| MA-I | 2024-02-26 |
View PIPER SANDLER & CO.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.